ID SYI1_PSEFL Reviewed; 943 AA. AC P18330; DT 01-NOV-1990, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1995, sequence version 2. DT 02-SEP-2026, entry version 145. DE RecName: Full=Isoleucine--tRNA ligase 1; DE EC=6.1.1.5; DE AltName: Full=Isoleucyl-tRNA synthetase 1; DE Short=IleRS 1; GN Name=ileS1; Synonyms=ileS; OS Pseudomonas fluorescens. OC Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria; OC Pseudomonadales; Pseudomonadaceae; Pseudomonas. OX NCBI_TaxID=294; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=ATCC 49323 / NCIMB 10586; RX PubMed=7929087; DOI=10.1016/s0021-9258(19)51082-1; RA Yanagisawa T., Lee J.T., Wu H.C., Kawakami M.; RT "Relationship of protein structure of isoleucyl-tRNA synthetase with RT pseudomonic acid resistance of Escherichia coli. A proposed mode of action RT of pseudomonic acid as an inhibitor of isoleucyl-tRNA synthetase."; RL J. Biol. Chem. 269:24304-24309(1994). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-29 AND 701-943. RC STRAIN=ATCC 49323 / NCIMB 10586; RX PubMed=2121716; DOI=10.1128/jb.172.11.6512-6517.1990; RA Isaki L., Beers R., Wu H.C.; RT "Nucleotide sequence of the Pseudomonas fluorescens signal peptidase II RT gene (lsp) and flanking genes."; RL J. Bacteriol. 172:6512-6517(1990). RN [3] RP RESISTANCE TO MUPIROCIN. RC STRAIN=ATCC 49323 / NCIMB 10586; RX PubMed=12672810; DOI=10.1074/jbc.m302633200; RA Yanagisawa T., Kawakami M.; RT "How does Pseudomonas fluorescens avoid suicide from its antibiotic RT pseudomonic acid? Evidence for two evolutionarily distinct isoleucyl-tRNA RT synthetases conferring self-defense."; RL J. Biol. Chem. 278:25887-25894(2003). CC -!- FUNCTION: Catalyzes the attachment of isoleucine to tRNA(Ile). As IleRS CC can inadvertently accommodate and process structurally similar amino CC acids such as valine, to avoid such errors it has two additional CC distinct tRNA(Ile)-dependent editing activities. One activity is CC designated as 'pretransfer' editing and involves the hydrolysis of CC activated Val-AMP. The other activity is designated 'posttransfer' CC editing and involves deacylation of mischarged Val-tRNA(Ile) (By CC similarity). {ECO:0000250}. CC -!- FUNCTION: Confers resistance to the antibiotic mupirocin (pseudomonic CC acid A), an Ile-analog produced by P.fluorescens NCIMB 10586 itself CC that competitively inhibits activation by Ile-tRNA synthetase, thus CC inhibiting protein biosynthesis. CC -!- CATALYTIC ACTIVITY: CC Reaction=tRNA(Ile) + L-isoleucine + ATP = L-isoleucyl-tRNA(Ile) + AMP + CC diphosphate; Xref=Rhea:RHEA:11060, Rhea:RHEA-COMP:9666, Rhea:RHEA- CC COMP:9695, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:58045, CC ChEBI:CHEBI:78442, ChEBI:CHEBI:78528, ChEBI:CHEBI:456215; EC=6.1.1.5; CC -!- COFACTOR: CC Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250}; CC Note=Binds 1 zinc ion per subunit. {ECO:0000250}; CC -!- SUBUNIT: Monomer. CC -!- SUBCELLULAR LOCATION: Cytoplasm. CC -!- DOMAIN: IleRS has two distinct active sites: one for aminoacylation and CC one for editing. The misactivated valine is translocated from the CC active site to the editing site, which sterically excludes the CC correctly activated isoleucine. The single editing site contains two CC valyl binding pockets, one specific for each substrate (Val-AMP or Val- CC tRNA(Ile)) (By similarity). {ECO:0000250}. CC -!- MISCELLANEOUS: P.fluorescens NCIMB 10586 possesses two distinct IleRSs CC (IleRS-R1 and IleRS-R2), each with a different level of sensitivity to CC mupirocin. Purified IleRs-R2 shows no sensitivity to mupirocin even at CC a concentration of 5 mM, 100'000 fold higher than the Ki value of CC IleRS-R1. CC -!- SIMILARITY: Belongs to the class-I aminoacyl-tRNA synthetase family. CC IleS type 1 subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X80132; CAA56431.1; -; Genomic_DNA. DR EMBL; M35366; AAA25883.1; -; Genomic_DNA. DR EMBL; M35367; AAA26022.1; ALT_SEQ; Genomic_DNA. DR PIR; A37152; A37152. DR AlphaFoldDB; P18330; -. DR SMR; P18330; -. DR eggNOG; COG0060; Bacteria. DR SABIO-RK; P18330; -. DR GO; GO:0005829; C:cytosol; IEA:TreeGrafter. DR GO; GO:0002161; F:aminoacyl-tRNA deacylase activity; IEA:InterPro. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule. DR GO; GO:0004822; F:isoleucine-tRNA ligase activity; IEA:UniProtKB-UniRule. DR GO; GO:0000049; F:tRNA binding; IEA:InterPro. DR GO; GO:0008270; F:zinc ion binding; IEA:UniProtKB-UniRule. DR GO; GO:0006428; P:isoleucyl-tRNA aminoacylation; IEA:UniProtKB-UniRule. DR CDD; cd07960; Anticodon_Ia_Ile_BEm; 1. DR FunFam; 1.10.730.20:FF:000001; Isoleucine--tRNA ligase; 1. DR FunFam; 3.40.50.620:FF:000042; Isoleucine--tRNA ligase; 1. DR FunFam; 3.40.50.620:FF:000048; Isoleucine--tRNA ligase; 1. DR Gene3D; 1.10.730.20; -; 1. DR Gene3D; 3.40.50.620; HUPs; 2. DR Gene3D; 3.90.740.10; Valyl/Leucyl/Isoleucyl-tRNA synthetase, editing domain; 1. DR HAMAP; MF_02002; Ile_tRNA_synth_type1; 1. DR InterPro; IPR001412; aa-tRNA-synth_I_CS. DR InterPro; IPR002300; aa-tRNA-synth_Ia. DR InterPro; IPR033708; Anticodon_Ile_BEm. DR InterPro; IPR002301; Ile-tRNA-ligase. DR InterPro; IPR023585; Ile-tRNA-ligase_type1. DR InterPro; IPR050081; Ile-tRNA_ligase. DR InterPro; IPR013155; M/V/L/I-tRNA-synth_anticd-bd. DR InterPro; IPR014729; Rossmann-like_a/b/a_fold. DR InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd. DR InterPro; IPR009008; Val/Leu/Ile-tRNA-synth_edit. DR InterPro; IPR010663; Znf_FPG/IleRS. DR NCBIfam; TIGR00392; ileS; 1. DR PANTHER; PTHR42765:SF1; ISOLEUCINE--TRNA LIGASE, MITOCHONDRIAL; 1. DR PANTHER; PTHR42765; SOLEUCYL-TRNA SYNTHETASE; 1. DR Pfam; PF08264; Anticodon_1; 1. DR Pfam; PF00133; tRNA-synt_1; 1. DR Pfam; PF06827; zf-FPG_IleRS; 1. DR PRINTS; PR00984; TRNASYNTHILE. DR SUPFAM; SSF47323; Anticodon-binding domain of a subclass of class I aminoacyl-tRNA synthetases; 1. DR SUPFAM; SSF52374; Nucleotidylyl transferase; 1. DR SUPFAM; SSF50677; ValRS/IleRS/LeuRS editing domain; 1. DR PROSITE; PS00178; AA_TRNA_LIGASE_I; 1. PE 3: Inferred from homology; KW Aminoacyl-tRNA synthetase; Antibiotic resistance; ATP-binding; Cytoplasm; KW Ligase; Metal-binding; Nucleotide-binding; Protein biosynthesis; Zinc. FT CHAIN 1..943 FT /note="Isoleucine--tRNA ligase 1" FT /id="PRO_0000098445" FT MOTIF 58..68 FT /note="'HIGH' region" FT MOTIF 608..612 FT /note="'KMSKS' region" FT BINDING 567 FT /ligand="L-isoleucyl-5'-AMP" FT /ligand_id="ChEBI:CHEBI:178002" FT /evidence="ECO:0000250" FT BINDING 611 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250" FT BINDING 906 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000250" FT BINDING 909 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000250" FT BINDING 926 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000250" FT BINDING 929 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000250" FT CONFLICT 28..29 FT /note="IL -> SC (in Ref. 2)" FT /evidence="ECO:0000305" FT CONFLICT 755..756 FT /note="QT -> DR (in Ref. 2)" FT /evidence="ECO:0000305" FT CONFLICT 758..759 FT /note="LY -> VP (in Ref. 2)" FT /evidence="ECO:0000305" FT CONFLICT 761..764 FT /note="ISEA -> QRR (in Ref. 2)" FT /evidence="ECO:0000305" SQ SEQUENCE 943 AA; 105719 MW; 6827B2BF2EB89FC0 CRC64; MTDYKATLNL PDTAFPMKAG LPQREPQILQ RWNSIGLYGK LREIGKDRPK FVLHDGPPYA NGTIHIGHAL NKILKDMILR SKTLSGFDAP YVPGWDCHGL PIEHKVEVTY GKNLGADKTR ELCRAYATEQ IEGQKSEFIR LGVLGEWDNP YKTMNFKNEA GEIRALAEIV KGGFVFKGLK PVNWCFDCGS ALAEAEVEYE DKKSSTIDVA FPIADDAKLA EAFGLASLAK PAAIVIWTTT PWTIPANQAL NVHPEFTYAL VDVGDRLLVL AEEMVESCLA RYELQGSVIA TATGSALELI NFRHPFYDRL SPVYLADYVE LGSGTGIVHC SPAYGVDDFV ICKKYGMVND DIINPVQSNG VYVPSLEFFG GQFIFKADQP IIEKLREVGA LMQTAAIQHS YMHCWRHKTP LIYRATAQWF IGMDKEPTSG DTLRVRSLKA IEDTKFVPSW GQARLHSMIA NRPDWCISRQ RNWGVPIPFF LNKESGELHP RTVELMEVVA QRVEQQGIEA WFKLDAAELL GDEAPLYDKI SDTLDVWFDS GTTHWHVLRG SHPMGHETGP RADLYLEGSD QHRGWFHSSL LTGCAIDNHA PYRELLTHGF TVDETGRKMS KSLKNVIEPK KINDTLGADI MRLWVASTDY SGEIAVSDQI LARSADAYRR IRNTARFMLS NLTGFNPASD LLPAEDMLAL DRWAVDRTLL LQRELQEHYG EYRFWNVYSK IHNFCVQELG GFYLDIIKDR QYTTGANSKA RRSAQTALYH ISEALVRWIA PILAFTADEL WEYLPGERNE SVMLNTWYEG LTELPADFEL GREYWEGVMA VKVAVNKELE VQRAAKAVGG NLQAEVTLFA EDGLTADLAK LSNELRFVLI TSTASLAPFT QAPADAVATE VPGLKLKVVK SAFPKCARCW HCREDVGVNP EHPEICGRCV DNISGEGEVR HYA //